MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: New Drug For Breast Cancer Prevention

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

New Drug For Breast Cancer Prevention

New Drug For Breast Cancer Prevention
One more breakthrough and one more addition to the armamentarium to fight against breast cancer. National Cancer Institute reports that one of the largest breast cancer studies ever done showed that the osteoporosis drug Raloxifene (Evista andreg;) is as effective as tamoxifen in the prevention of breast cancer.

Raloxifene (Evista andreg;) has a lower side effort profile compared to tamoxifen and has 36 percent fewer uterine cancer risk and about 30 percent fewer risk of blood compared to Tamoxifen.

Tamoxifen is indicated for women who are at high risk of developing breast cancer for example those women who carry BRCA mutations. Since Raloxifene is as effective as tamoxifen with lesser side effects, this drug may soon replace Tamoxifen for prevention of breast cancer in high-risk women. Raloxifene needs approval from FDA as a breast cancer prevention drug before it could be used for this purpose.

Currently an estimate 500,000 women use Raloxifene to reduce the risk of osteoporosis, so it is expected that a number of women will be comfortable using it for breast cancer prevention.

"There is something proactive you can do if you're at higher than average risk of getting breast cancer," said Dr. James Stewart who is the director of the breast cancer program at the UW Comprehensive Cancer Center. "The sticky part of it will be sitting down with your doctor to talk about are the expected benefits worth it".

"This is good news for women," said Leslie Ford of the National Cancer Institute, which sponsored the $88 million study and released the preliminary findings early because of their public health implications. "Women now have a new option".




Did you know?
One more breakthrough and one more addition to the armamentarium to fight against breast cancer. National Cancer Institute reports that one of the largest breast cancer studies ever done showed that the osteoporosis drug Raloxifene (Evista andreg;) is as effective as tamoxifen in the prevention of breast cancer.

Medicineworld.org: New Drug For Breast Cancer Prevention

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.